ANALYSIS: What now for EU medtech reforms?
This article was originally published in SRA
Executive Summary
So what's next for the proposals for a new regulatory framework for medical devices and in vitro diagnostics in the EU? And who will influence the way ahead? Amanda Maxwell looks at the views of the member states, the main stumbling blocks to further progress and how the cost of implementing the regulations is moving up the agenda.